Disclosure of notification received from AOC Pharma S.à r.l.
08 Ottobre 2024 - 10:00PM
UK Regulatory
Disclosure of notification received from AOC Pharma S.à r.l.
Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 8 October 2024 –
9:00 PM CET
Disclosure of notification received from AOC Pharma S.à
r.l.
Pursuant to the Belgian law of 2 May 2007 regarding the
disclosure of major shareholdings in listed companies, Fagron
received a notification from AOC Pharma S.à r.l.
Notification by AOC Pharma S.à r.l.
- On 3 October 2024, Fagron received a notification that changes
took place in the chain of controlled undertakings through which
the shares in Fagron NV are effectively held, be it that no
notification threshold has been crossed (downwards nor upwards),
and that the total number of shares held by AOC Pharma S.à r.l. has
not changed.
- The notification is made by a ‘parent undertaking or a
controlling person’.
- On 19 December 2023, AOC Pharma S.à r.l. held a total of
8,102,492 voting rights.
- Based on the denominator of 73,228,904 (total number of voting
rights), AOC Pharma S.à r.l. held 11.06% of the total number of
voting rights on 19 December 2023.
- The chain of controlled undertakings is as follows:
- AOC Pharma S.à r.l. is controlled by Active Ownership Fund
SICAV-FIS SCS.
- Active Ownership Capital S.à r.l. is the general partner of
Active Ownership Fund SICAV-FIS SCS.
- On 1 October 2019, an agreement was concluded by Active
Ownership Fund SICAV-FIS SCS regarding the appointment of Active
Ownership Corporation S.à r.l. as AIFM (alternative investment fund
manager) for Active Ownership Fund SICAV-FIS SCS. Pursuant to this
agreement and appointment Active Ownership Corporation S.à r.l will
exercise the voting rights with respect to shares held by Active
Ownership Fund SICAV-FIS SCS.
- Active Ownership Corporation S.à r.l. and Active Ownership
Capital S.à r.l. are both controlled by Active Ownership Group Ltd.
(Cyprus).
- Active Ownership Group Ltd. (Cyprus) is jointly controlled by
two shareholders, Active Ownership Advisors GmbH and Active
Ownership Investments Ltd. (Cyprus).
- Active Ownership Advisors GmbH is controlled by Florian
Schuhbauer.
- Active Ownership Investments Ltd. is controlled by Active
Ownership LP (Cyprus), which is controlled by Active Ownership
Management Ltd. (Cyprus), which is controlled by Klaus Röhrig.
- On the date of the notification, 3 October 2024, AOC Pharma S.à
r.l. directly holds 11.06% of the voting rights in Fagron NV.
- The notification of Active Ownership Corporation S.à r.l. can
be viewed via this link.
Further information
Karin de Jong
Chief Financial Officer
investors@fagron.com
About Fagron
Fagron is a leading global company active in pharmaceutical
compounding, focusing on delivering personalized medicine to
hospitals, pharmacies, clinics, and patients in more than 30
countries around the world.
Belgian company Fagron NV has its registered office in Nazareth
and is listed on Euronext Brussels and Euronext Amsterdam under the
ticker symbol ‘FAGR’. Fagron’s operational activities are managed
by the Dutch company Fagron BV, which is headquartered in
Rotterdam.
Important information regarding forward-looking
statements
Certain statements in this press release may be deemed to be
forward-looking. Such forward-looking statements are based on
current expectations and are influenced by various risks and
uncertainties. Consequently, Fagron cannot provide any guarantee
that such forward-looking statements will, in fact, materialize and
cannot accept any obligation to update or revise any
forward-looking statement as a result of new information, future
events or for any other reason.
In the event of differences between the English translation
and the Dutch original of this press release, the latter
prevails.
- Disclosure of notification received from AOC Pharma S a r
l
Grafico Azioni Fagron NV (EU:FAGR)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Fagron NV (EU:FAGR)
Storico
Da Dic 2023 a Dic 2024
